Cannabis Breeder’s Rights: Open Source Genetics for Hemp and Marijuana

SEATTLE — LeBlanc CNE, Inc. released a licensing framework for cannabis breeders similar to an open source approach for digital content. Inspired by Creative Commons and DJ Short, the Cannabis Breeder’s Rights allow hemp and marijuana breeders to convey their wishes and intentions of the genetics they release. [ www.LeBlancCNE.com/cannabis-breeders-rights/ ]

The Cannabis Breeder’s Rights has been published on Academia.edu. [ https://www.academia.edu/21432883/Cannabis_Breeders_Rights ] Included is a spreadsheet outlining the detailed descriptions of the 20 different licenses and a widget to help select the appropriate license.

“I don’t want to own my strains. I don’t want to patent it. But my biggest fear is that someone else will take my work and prevent me from working with it. And I see as the only solution to this is to make all of this public domain and open source,” DJ Short, Seattle Hempfest 2015.

Creative Commons licenses are used for music, photography, software and other creative works. They do not address the needs of hemp and marijuana breeders and growers, and there are no working models for open source genetics. The 20 different Cannabis Breeder’s Rights licenses cover standard commercial seed terms (no propagation, for sale, credit) to casual exchanges between fellow gardeners (no propagation restrictions, free, anonymous).

“We won The War on Drugs. One of the spoils of war is that we get to bring our sharing culture with us,” says Jerry Whiting, LeBlanc CNE founder and President. “People having been nurturing and sharing cannabis genetics for generations. We are guardians and custodians of this wonderful plant, not owners and hoarders driven by profits.”

Many who cultivate cannabis aren’t interested in patenting the genetics, even when it becomes legal to do so under federal law, but they do want flexible licensing terms. Those who seek patents, trademarks and other existing protections can still designate Cannabis Breeder’s Rights licenses as well.

Legalization is bringing both hemp and marijuana into the mainstream. However, since growing both has been illegal for so long the genetics have been developed in secret. Soon the normalization of cannabis will include everything from large scale agriculture to smaller artisan growers to home gardeners. Big money is at stake and not everyone believes genetics are private property.


 

LeBlanc CNE, Inc.
Founded by cannabis activist Jerry Whiting, LeBlanc CNE, Inc. specializes in cannabis genetics, software and biopharmaceuticals. LeBlanc CNE is a small, family-owned business dedicated to organic, whole plant based sustainable practices and values. Whiting speaks and teaches across the country, and is the lead developer of Althea, the cannabis software framework.

End


CannaCon, Cannabis Extravaganza Event, Comes to Seattle Feb. 18-20

The largest cannabis industry networking event of the year kicks off tomorrow in Seattle at Pier 91.

CannaCon is a three-day cannabis extravaganza complete with business seminars, glassblowing expos, shopping opportunities for all of the newest marijuana products, and a myriad other unique canna-business networking opportunities. Seminar doors open at 9 a.m. tomorrow, and Expo doors will open at 10 a.m.

There will be many different options available for food at the event. Ticket prices can vary dramatically, but $300 nets you full access to all expos and seminars during the entire 3-day event (must be registered beforehand).

For more information about exhibitors, see the CannaCon Floor Plan & Exhibitor Booth Map.

Ganjapreneur podcast host Shango Los will be attending, offering live Twitter updates of the event — so come say hello if you want to chat!

Attendance at CannaCon has risen dramatically over the past several years, with close to 6,000 attendees for the 2014 event and nearly 11,000 in 2015.

End


Oregon Bill to Reform Cannabis Banking Passes in the House

A bill designed to ease banks’ fears about providing services to the marijuana industry, HB 4094, passed in the Oregon House and is moving to the Senate for a final vote.

Oregon’s marijuana industry is in the midst a cash crisis. Federal law places a restrictive burden on banks who might provide services to legal marijuana businesses, leaving the industry flooded with cash — a dangerous proposition.

The bill amends state law to remove liability from banks who do business with legal marijuana, and also compels the Department of Consumer and Business Services (DCBS) to explore a new banking reform plan.

“This is an important first step in reducing risk and providing security for banks, credit unions, and the public,” said Tobias Read, the bill’s sponsor in the House of Representatives. It is a temporary solution, but a much-needed one.

Advocates hope that the move by Oregon will send a signal to Congress that banking reform for legal cannabis is needed at the federal level.

End


Denver Organizers Denied High Times Cannabis Cup Permit

Organizers of Colorado’s High Times Cannabis Cup have been denied a permit for the April event, reports The Denver Post. Adams County commissioners struck down the request unanimously, saying the event is neither safe nor legally compliant.

The commissioners heard testimony from local law enforcement, who argued that too many participants used cannabis products openly.

North Metro Drug Task Force Commander Todd Reeves said that last year, a military veteran had trouble breathing after sampling cannabis and that a woman leapt from a moving automobile.

“From a safety perspective, I have serious concerns about this event and this venue,” said Adams County Sheriff Michael McIntosh.

The Colorado High Times event is the magazine’s and perhaps the world’s largest cannabis event.

High Times general counsel Cristina Buccola said she was unaware of the permit’s denial and declined to comment on the event’s future.

John Doyle, co-owner of the Denver Mart, which had applied for the permit, had presented the commission with new, stricter set of rules for the event. Total attendees would have been limited to 15,000 per day, as opposed to 35,000 last year, and visitors would have been required to find off-site parking before taking a shuttle to the event.

Commander Reeves said that the total number of attendees would exceed the 15,000 person limit set by fire officials by another thousand when vendors were included, and that the organizers had failed to address the fact that public consumption of cannabis remains illegal in Colorado.

End


Ken “K” Morrow: Learning from Trichome Technologies

Ken “K” Morrow of Trichome Technologies has been at the forefront of cannabis horticulture for decades. His writing has appeared in High Times magazine 50 times over the last 15 years. He has won 9 California Cannabis Cups between 1997 and 2000, has worked as a consultant to many of the top cannabis activists, legislators, scientists and doctors, and he also recently published Marijuana Horticulture Fundamentals, a comprehensive guide to cannabis cultivation and production. K recently joined our podcast host Shango Los for a discussion about his long career in the cannabis industry, what it’s like to witness legalization happening after spending so much time as a prohibition-era grower, how hash making processes have evolved over time, and more!

Listen to the podcast below, or scroll down to read the full transcript.

Subscribe to the Ganjapreneur podcast on iTunes, Stitcher, SoundCloud or Google Play.


Listen to the podcast:


Read the full transcript:

Shango Los: Hi there and welcome to the Ganjapreneur.com podcast, I am your host, Shango Los. The Ganjapreneur.com podcast gives us an opportunity to speak directly to entrepreneurs, cannabis growers, product developers and cannabis medicine researchers all focused on making the most of cannabis normalization. As your host I do my best to bring you original cannabis industry ideas that will ignite your own entrepreneurial spark and give you actionable information to improve your business strategy and improve your health and the health of cannabis patients everywhere. Today my guest is Ken Morrow, a fellow much better known over the last 30 years as K. from Trichome Technologies.

Ken is truly an OG, he has been at the forefront of cannabis horticulture for decades, his writing has appeared in High Times magazine 50 times in the last 15 years. But perhaps his greatest influence has been sharing his experiences informally to small groups, individuals and mentoring others online. In 1999 he was chosen by High Times magazine as having the best grow room in their 25 year history, between 1997 and 2000 he won 9 California Cannabis Cups. He has consulted for many of the top activists, legislators, research scientists and doctors and was featured on an episode of 60 Minutes and has appeared on CNN. K has just published a gorgeous new book title, Marijuana Horticulture Fundamentals, a comprehensive guide to cannabis cultivation and hash production.

Today we’re going to talk about his new book, some cannabis cultivation history and his deep knowledge of hash making techniques. Thanks for being on the show Ken.

K. Morrow: Thank you very much Shango for having me, it’s a pleasure.

Shango Los: Ken, having participated in cannabis for the last 30 years, to see some cannabis legalization finally happening has got to be both a shock and a relief. What has this experience been like for you?

K. Morrow: Shocking to say the least, to see politicians embrace us, to see the whole movement moving forward is just, I honest, me and my friends. Speaking with Mel Frank the other day, never really seen this way happening in reality.

Shango Los: It must be really encouraging to, because we all, back in the prohibition days we were like, if we could only live long enough to see legalization and it’s like, holy smokes it’s here. That must be really gratifying for somebody like you who did so many years of research under prohibition where it was a combination of taboo, disrespect and trying to not get in trouble. It must be a real liberating feeling now to finally be able to step out and have at it.

K. Morrow: Let’s just say it’s gratifying to be proven right in the end. You know, as I said, speaking with Mel Frank yesterday, he’s approaching 70 and he thought he was retired and that was the end of the game and he’s never been so busy as he is right now, it’s incredible. Someone suggested he put his photos in a art exhibit and he literally doesn’t have time to do so.

Shango Los: Good for him, so what has it been like for you going from kind of the shadows of cannabis. I mean you were known as K from Tricome Technologies and now we’re like audaciously saying your name, Ken Morrow, on the air. What does that feel for you to come out from where you are a thought leader in the industry but you had to use a pseudonym to still being a thought leader in the industry. But being able to claim that respect with your real name.

K. Morrow: Still every time someone approaches me and uses my first and last name I expect them to pull out a badge, and that’s reality, you know. It’s shocking to me, it’s very humbling, I’m not really the type of person to be in the spotlight so to speak. It takes me aback a little bit.

Shango Los: Right on, well you’re definitely going to be in the spotlight even more here in the next few months promoting your new book, congratulations on that. It is a really gorgeous volume, one of the things I appreciate most about it is the conversational tone you take, reading it feels like hanging out with you and just having you explain it to me and it makes the writing really immersive. I also appreciated that the book isn’t just packed with bud photos like some are, your photos are very explanatory of what you’re trying to say and they really support your writing. Did you find it challenging distilling your vast 30 years of experience into a single book?

K. Morrow: It was kind of unusual but, like I kept it to the basic fundamentals, just teaching people how to do, what to do and all that kind of stuff was just kind of start at step 1 and go to step 100 kind of sort of thing. Thank you very much for your kind words, it’s a labor of love first and foremost and the limited amount of pictures that are in the book also reflect my amount of work. 40% of the photos in the book are actually my work, I actually did the work, grew the plants, manicured them, dried them, cured them, cloned them, everything else. I’m very proud of that fact that most of the work in the book I did myself.

Shango Los: Well and you can really feel that too because when somebody is taking photographs, say for an internet forum or something and the goal is to show how to do something, they show pictures that are very step by step and that’s what I experienced with your book too. I got to say, when you say the limited photos in your book, you must mean limited versus what you have totally because I thought the book was jam packed, I mean it’s colorful, it’s beautiful. There’s plenty of real solid narrative and you’re explaining me how to do things but it is, there’s so many pictures there that if pictures say a thousand words. It’s as if the book is four times the length because the pictures that you have taken intentionally really do a lot to explain what you’re trying to break down.

Had you always wanted to write a book, since you are already a writer for High Times, or did somebody give you an idea or even beg you to do it?

K. Morrow: Well I was fortunate enough that I knew the owners of Green County Press and they gave me the opportunities and the qualities that you are speaking of. The layout, the design, the color, everything else, the credit really does to Green County Press, their team, everything else. I just wrote the words, I’m proud of the photographers, they’re some of the best photographers in the industry. From Mel Frank, to Bubble man, to Andre Grossman on and on and on. One of the things I’m proudest of in the book is that I was able to give love back to my community, if you look at the acknowledgments, if you look at the references. I explain to people this isn’t the best book, if you buy the book from George Savantes, from Mel Frank, from Ed Rosenthal, from Robert Connel-Clark. If you buy all the information, read all the information then you’ve got a tenth of the picture so to speak, so I’m very, very proud that I’ve got to give love back to people like Thomas Alexander who did the magazine. Sensinalia Tips and many other obscure individuals that people don’t know who they are but, this is how we got where we are today.

I really, really took pride in giving credit to the people that came before me.

Shango Los: That’s really great, you know, another think that I liked about the book is you know, when I was in college and just starting to read these books. The only publishers, like C level, D level publishers were putting out these books and they, you know the binding wasn’t very good and the pictures were kind of a drag and sometimes things were out of focus. But now that people can get behind this and the quality is going up, it’s really a beautiful volume and that’s nice. Because you’re right, there are several different books that you can pick up and only know a tenth of what you will eventually know as a cultivator but it sure is a pleasurable experience when it looks good in your hands.

K. Morrow: Thank you very much.

Shango Los: Right on, so what do you say Ken is one of the most under publicized but extremely helpful new techniques or piece of information that growers should know?

K. Morrow: Right now it’s just, how to you start with your design of your facility, with the mass proliferation of cultivated marijuana in the United States, the wholesale prices dropping, dropping, dropping. The number one piece of advice I can give is be mindful of your actual costs of production, I mean if you’re selling grams for $6.00 but but it costs you $9.00 to produce you’ll very soon be out of business. Be mindful of when you’re creating you’re efficiency to not cut corners because you can create efficient production and still produce top quality cannabis is what I’m saying. That’s the whole thing, is really mindful of your actual cost production and the efficiency of your production facility is the biggest thing I can say.

Shango Los: If we’re going to be talking specifically about saving money and efficiency, are you down with LED lights now?

K. Morrow: Yeah, well LED lights and induction lights are fantastic for cloning and fantastic for vegetative, not for flowering in my opinion at this point. They will get to that level very soon but, a large scale facility I’ve very rarely see an LED bank over their flowering production facility.

Shango Los: It’s amazing that LED is going to have to give up a lot of the bad reputation it had before it had gotten this far. You know, in the early days people were like, let’s use LED and then everything was all laggy and it didn’t work right. But now there’s been so many jumps forward in the technology and the ability to really hone at 6,700K or whatever you want to grow at, to be able to adjust that. The technology really has come a long way, before we go to the break, what’s another good efficiency tool that you think that new school grow rooms should have?

K. Morrow: On a large scale I explain to people the matrix is from what I see it being now is 90% of the product that’s produced today is going to end up turning into concentrates, people are only going to consume the top 10%, the best of the best. The rest of it will be ripened up, once it’s ripened up in a two week period you’re going to get a accentuated level of cannabinoids and terpenoids, up to 25%. In that two week period, if you get up take of and ripening of your desirable compounds like I said, by eliminating the process of cutting them down, replacing them, utilizing that square footage efficiently and properly, ripening up that lower material if you will. You’re going to get a 25% increase, that will take two weeks, two weeks times four is eight weeks, that’s a whole flowering cycle. If you can get the same amount of cannabinoids and terpenoids by ripening up the same material, you get to skip one growth cycle but get the same amount of desirable components.

Therefore you save the money on that whole production cycle then you’re going to turn around and you’re going to, since you only took 10%, the other 90% is going to get fresh frozen so you’re not going to really dry cure, you don’t have to build a huge drying and curing facility for that purpose if you will and the equipment and the labor associated with that process. On a 36,000 square foot facility one of my clients spends between $100-140,000 dollars per month to trim 400 pounds and this is a monthly cost. Well the other 90% won’t be dried, it won’t be cured, it won’t be trimmed so you can eliminate that cost, that stuff will be fresh frozen and extracted. By doing so you’ll get an increased level of terpene content by the simple action of drying you’ll lose up to 30% of the available terpenes on the plant. So by not drying and not curing you saved all the labor costs, production costs, everything associated with it and the final product is a terpene rich concentrate that you can turn into anything you want from there. Therefore, that’s the matrix and that’s how you produced and saved yourself millions of dollars in drying, curing and space allocation.

Shango Los: That is such a beautiful and elegant solution and one other great thing about it is that it is simply a different way of thinking about it instead of actually having to spend money on some kind of new equipment. But we’re going to take a short break and be right back, you are listening to the Ganjapreneur.com podcast.

Welcome back, you are listening to the Ganjapreneur.com podcast, I am your host Shango Los and our guest this week is K from Trichome Technologies. So K, when you were getting into all this 30 years ago, you guys were breeding with landraces and seeds were coming in and shipments, a lot of you guys were going out and traveling internationally and looking for the seeds and bringing them back. But really you were the building blocks, where landraces, the way mother nature had created them in these bio regions all across the globe. Well now a days it’s harder for them to get their hands on the landraces both because we’ve got so many hybrids that are in the economy now, that people can just start with a high quality hybrid instead of a landrace. But also a lot of the landraces in these generally third world countries have been muddied by breeders taking their genetics there to trade. What have you seen has been the big difference between working with landraces for breeding like you did 20-30 years ago versus working with hybrids primarily, which is what people are doing now?

K. Morrow: Well hybrids are much more stable, back in the day when you were dealing with landraces you would go and you would breed new plants and the genetic diversity that you got from the progeny of those plants was very, very, very diverse. With the hybrids it’s a little bit closer, you’re still dealing with a massive amount of genetic diversity if you will but not as wide. You know with the old landraces you could get anything, you know, short, squat, tall. Usually undesirable, very, very lanky and a long, long growth cycle so, both through breeding, genetic selection if you will, turning out the hybrids. The hybrids, you know, you’re still going to get a lot of diversity but certainly not as much as you would with the old school hybrids.

Shango Los: You know I must admit I’m kind of surprised by your answer, I thought you were going to tell me we had whittled down our genetic diversity in a negative way because the original landraces had held so many options. But actually what I’m gathering is those wild plants and those wild seeds they were harder for breeders because they were like a bucking bronco. Whereas the hybrids now have been settled down to the point where that you can still draw out genetic diversity but, there’s a lot less static and noise in the signal. Am I, am I picking up what you’re putting down?

K. Morrow: Yeah, but understand that’s kind of speculation on my part, there’s still a lot of those landraces out there available that have been collected and we really don’t know what the benefits of those plants are because we’re just coming into the age of proper analyzation if you will, what if the old Whahakin from 1977 had a elevated level of a desirable component that we’ve somewhat lost. In the future I expect it will go back and cherry pick some of those to breed them into our current hybrids if you will.

Shango Los: You know a couple times on this show over the last couple months we’ve gotten to the conversation of how technology is helping breeding and we had a really good show with Reggie Gaudino from Steep Hill. Talking about what will be necessary to get patents on these plants and he was suggesting F9 is going to be necessary and how much nicer it is to be able to work with the technology that’s available now to find out so much more about the genetics of the plants and not have to grow them up to maturity. In what ways are you using some of these new technology tricks that are available to us to better your own breeding program?

K. Morrow: There’s only 3-4 genetic programs going on right now and for the benefit of the industry they’re not really focusing on genetically modified cannabis because fortunately nobody really wants this and so I don’t really see it being profitable. People talk about, you know, I won’t mention the names but multiple large scale corporations coming in and monopolizing this throughout their genetics. I just don’t see that really happening because you’ve got multiple programs right now doing DNA research, I believe that that DNA research will guide the selections of genetics we breed in the future and as the great David Watson pointed out, it’s much easier to get the desirable results or compounds or whatever you’re looking for by selective breeding then genetic modify. That’s what I’m looking for right now is to see if, multiple times have mapped the cannabis gene, both sativa, hemp, this that and the other thing. Someone in Canada with a Purple Kush and another hemp variety and I think that that technology is really going to aid in producing the desirable strains, varietals, compounds that we want in the future.

Not varietals but cultavirals if you will.

Shango Los: Yeah, yeah, so I understand from talking to you the other day that one of the things that really has got you juiced right now is doing extractions and you know, you’ve been doing extractions for decades. But specifically doing extractions to isolate particular aspects of the plant that meet particular patient needs so that you can customize an extraction for them to either take orally or to smoke that will help their particular ailment. Tell us a little bit about how you’ve been approaching that?

K. Morrow: Well it’s just, as a kid wants to take apart a toy, I look at the, once you’ve extracted something you understand that there’s multiple components. Well how do you separate those components, so you go back into basic organic chemistry but then you’ve got to go look at other people’s patents and equipment used and stuff, pick pieces and parts from other industries to try to accomplish your goal if you will. But, you know, how do you separate THC’s from CBD? Well me and multiple other people have figured out that be it from either the drug cultivars or the hemp cultivars. Then you separate the terpenes, well how do you fraction-ate the terpenes into the separate compounds and do that. It was just a fascination thing, you know, challenge myself, see if I could, try to figure out how. Now I’ve figured them out and I’ve separated them all, I’m not qualified to say or speak about what they’re good for or what they do.

I consider myself just a formulator, I formulate products that are going to be utilized by medicinal corporations if you will in the future. That’s all I’m really trying to do is formulate products to, when the members of the International Cannabinoid Research Society or the Research Institute of Pharmaceutical Sciences wants pure pharmaceutical grade compounds that they can research, I want to be the person that provides them.

Shango Los: Right on, so I’ve got a question for you, but I want to say up front that this is not a leading question, I don’t have an opinion on this. I am looking at this for your opinion. We’re all big fans of whole plant medicine, the entourage effect, we’ve had Ethan Russo on the show talking about how the THC, the terpenes and the cannabanoids are all working together in concert. What do you feel about teasing apart the plant to find it’s discreet parts and then putting them together into a customizable oil? Do you still feel that that is whole plant medicine at that point?

K. Morrow: Whether it is or whether it isn’t, say that you just separated betakeraphaline oxide from a cannabis plant or some other compound that you couldn’t get from another source. If you found out that there was an ailment that that basic component was good for you might put that whole compound back on to the whole plant extracts. Yes, there’s going to be some ailments that you know, require or are treatable by certain compounds, so why would you give them a whole plant extract if they don’t need a whole plant extract? If they just need part A, part B, part C, I mean based on the anecdotal evidence I see this thing has multiple, multiple benefits. I can’t see that the exact chemical composition and ratio is fixing all those different things and maybe one would be helped if it had an accelerated or a higher level of a different component. That’s kind of, I’m not, again qualified to speak but that’s what I’m trying to put together. If someone figures out that I’ve got this great whole plant extract that I wish had more betakeraphaline in, okay boom, there you go.

Shango Los: Right, that actually kind of teases out a new in-between position that I haven’t seen before because you know a lot of people really got into whole plant medicine after Merinol came out. That just isolated THC and didn’t have nearly as good as an effect as whole plant medicine does. But you’re right, with the new technologies and with the new research that guys like you and others are doing, we actually can kind of rebuild a whole plant without just isolating one single part. I’m going to have to mull on that in the shower a little bit. But also for right now we need to take another break. You are listening to the Ganjapreneur.com podcast.

Welcome back, you are listening to the Ganjapreneur.com podcast, I am your host Shango Los and our guest this week is K from Trichome Technologies. Right before the break we were talking about the evolution from just growing cannabis to all of the new school extraction techniques and you know Ken you were there in the early days when people first started talking about BHO. Would you give us a little time machine moment and go back because we’re all excited about extracts now and comparing/contrasting, just give us a little snapshot about what it was like when people started moving beyond just simple hash and into hash oils and these new extraction techniques?

K. Morrow: Well it’s kind of a weird evolution, first cannabis started getting better and better and better so it started producing accelerated levels of THC on the waste materials, be it the trim. I started playing with the trim. There was no internet, there was no information, you couldn’t figure out how to do this so I started. You know, there was very few books or information on how to make hashish, the art was kind of lost in North America until the book from Robert Connel-Clark called Hashish came out and then it demystified everything. But, so I started breeding cannabis and that cannabis produced accentuated levels of chemicals, well I wanted to isolate those chemicals so I taught myself dry sieve.

Then I got a piece of communications from Neville Shoemacker and David Watson that kind of basically, loosely explained the water separation method. So I delved into that and published with Mel Frank the first water hash and dry sieve article in High Times magazine in 2000. Very soon after that produced the very first BHO abstraction article for Red Eye Magazine, in the year 2000 for Red Eye Magazine. 16 years ago explaining the process of BHO extraction but also write the first Rick Simpson article long before he did I just didn’t claim it had a care for cancer, anything like that. It was just a raw hash oil extraction, something the people had been doing for thousands of years so I certainly didn’t invent it or anything else.

I’ve been participating in the concentrate thing for a very long time, so the butane thing, you know, just the raw extraction from trim. But then you started extracting from bud and how do you super refine, how do you refine … a video called medicinalalchemy.com came out, that kind of pushed the industry forward. It taught the person how to make shatter or butter at their house, so that kind of proliferated, helped the industry go.

But the High Times Cannabis Cups, people meet every month and they share information, the internet, they just started to literally explode and then the processes of winterization and the uses of application like vacuum drying ovens or rotary vaporization apparatuses or close loop systems. People are getting hard core crash courses in organic chemistry in the past two years so, to see the thing massively proliferate like this has just been something to watch in the past two years it’s pretty incredible.

Shango Los: Yeah it is really exciting and it’s also kind of strange too to some of the early prohibition growers. I remember the first time I explained a nug run to you know, somebody who’d been growing since 1976, he was aghast right? Because he grows these beautiful flowers and he wants to take care of them and the idea that we were going to put it in a mechanical extraction technique to take out the essential parts was like, some kind of heresy. When you first started doing this all those years ago, were you getting that kind of push back too? You know, that’s cute what you’re doing but what the hell are you doing?

K. Morrow: Yeah, well it didn’t really become commercially viable until like I said, the wholesale price of cannabis dropped. I mean at this point, you know, you can get more for the concentrate than you can the raw flower, so the dynamic has really, really shifted. Once you explain to that individual, I’m going to take your beautiful flowers and turn them into something more desirable on the open market then he completely understands and that’s where it goes.

Shango Los: Yeah, that’s a good point, and that’s probably the big difference too between in the early days you were just using trim, which used to be called trash, which is now totally not trash versus the prices coming down so much that you can use flower. Also probably, there’s probably more people growing now then there ever has been and so there a lot more you know, B- and lower flower on the market that doesn’t have to bag appeal to even be sold at retail, so there’s just more of it in general probably too.

K. Morrow: Correct.

Shango Los: In the early days did you kind of you know, Johnny Appleseed it a bit, you’re very clear that you know, you shared bringing this knowledge out with other people and that is good. But in your own world were you finding that you were going around kind of turning people on to this technique and blowing their minds? Much like you know, people are doing now by turning on their friends to doing a rosin press and hair straightener and like everybody thinks they’re a Demi God. I can imagine that as you were taking this run and showing people their mind was kind of blown.

K. Morrow: Kind of stayed to myself, so I just showed to to a very small handful of friends you know, Ed Rosenthal, Rob Clark, people like that. I don’t really go out and show my wares just for the sake of showing my wares, you know.

Shango Los: Right on and if you’re going to talk about the people you showed it to you certainly named two out of the pantheon right? Ed and Bob so, well.

K.” Morrow: I explained I only got where I am because of people like them.

Shango Los: Right on, we’re all standing on somebody else’s shoulders right?

K. Morrow: For sure, for sure.

Shango Los: Ken, that’s all the time that we’ve got for today. Thank you so much for being on the show and sharing your vast experience with us.

K. Morrow: Thank you so much for having me it’s really been a pleasure.

Shango Los: You can find out more about Ken Morrow, his speaking engagements and his new book Marijuana Horticultural Fundamentals, a comprehensive guide to cannabis cultivation, has production on his Facebook page. At Facebook.com/TrichomeTechnologies. We also have a link to his book on Amazon in the notes attached to this podcast, you can find more episodes of the Ganjapreneur podcast in the podcast section at Ganjapreneur.com and also in the Apple Itunes store. One the Ganjapreneur website you will the latest cannabis news, product reviews and cannabis jobs updated daily, along with transcriptions of this podcast. You can also download the Ganjapreneur.com app in Itunes ad Google Play. You can also find the show on the I Heart Radio Network app, bringing the Ganjapreneur podcast to 60 million mobile devices.

Do you have a company that wants to reach our national audience of cannabis enthusiasts? Go ahead and email us at grow@Ganjapreneur.com to find out how. Thanks as always to Brasco for producing our show, I am your host Shango Los.

End


Matthew Feinstein: Laying the Groundwork for a National Cannabis Franchise

Matthew Feinstein is the co-founder and CEO of Pineapple Express, a publicly-traded company based out of California which is in the process of developing a national cannabis retail franchise.

Pineapple Express also has several other projects in the works, including their recent acquisition of the THC.com website and trademark, as well as a large facility in Desert Hot Springs, CA with 10 warehouses for cannabis production, one of which they have already rented out. We recently got in touch with Matthew to learn a bit more about what Pineapple Express has planned for 2016 and beyond! Read the full interview below:


Ganjapreneur: What was your career before Pineapple Express, and what motivated your decision to start your own cannabis industry venture?

Matthew Feinstein: After I graduated UC Berkeley in 1991, my family and I owned and operated a video rental chain of video rental stores on military bases in in supermarkets across the country. We had close to 400 company owned and franchised stores and we were based in Los Angeles. In 1999, I moved to New York for a couple years to head up the purchasing, marketing, and merchandising group for a new e-commerce site called urbanfetch.com. In 2000, I moved back to LA to start my own DVD distribution company called Starlight Home Entertainment. My company was the exclusive distributor of all Lifetime TV and Oxygen Network DVD programming and we manufactured, distributed, and sold the DVDs to all the key retailers such as Wal*Mart, Blockbuster, Target, and Redbox. When I saw that the DVD industry was shrinking and less and less people were renting and purchasing DVDs, I went to work for one of my favorite customers, Redbox. There, I was able to transition from the Home Entertainment industry into the automated retail (kiosk) industry. It was around the time that I learned there was not a lot of room for advancement in this company, when I heard about a cannabis company called Medbox. In 2013 I became VP and a Director for that company. I assisted many clients in the dispensary and cultivation center application process in states such as Illinois, Nevada, Washington, Oregon, and California. I also assisted with store build out, operations, and training. Management changed at Medbox, and the Founder and I started a new publicly traded company called Pineapple Express [Ticker Symbol: PNPL].

What advantages does Pineapple Express gain by being a publicly-traded company as opposed to a private company?

Being publicly traded helps us gain more visibility. Visibility is important when building the brands Pineapple Express and THC.com — it also opens up more funding for our company and the projects that we are working on.

As a publicly-traded company, do you think you will face increased scrutiny from the federal government regarding your involvement in a federally illegal industry?

We are landlords and consultants. We don’t touch the plant. We invest, expand, and brand. We offer capital infusions to canna-businesses, we assist with their expansions, and we help them with their brand.

You recently announced that you were acquiring the THC.com domain name and trademark: can you give us any hints about what you have in store for this juggernaut cannabis brand?

We just finalized our acquisition of THC.com. We are also meeting with many experts to decide exactly what where we should take the website. We will be taking a company that has been operating since 1996 and investing, expanding, and marketing to promote its brand. Currently the site sells the THC branded clothing line and other types of apparel and items aimed towards the cannabis community. With the current scramble to brand and trademark marijuana industry related products, we believe we have hit a home run by acquiring the THC trademark for certain apparel items and the popular URL name and website. The organic website traffic and direct internet searches alone make it valuable.

What is the current status of your facility in Desert Hot Springs, CA? What is the long-term vision for the project?

We are super excited about our Pineapple Park project in Desert Hot Springs, California. Currently various news reports are stating more than 160 California cities and counties have proposed or already enacted bans within their city or county limits on commercial and/or personal cultivation of medical cannabis. Desert Hot Springs is the first Southern California city with a framework in place allowing cannabis cultivation facilities to exist. We have purchased and are in escrow of over 8 acres of land there. We are going to eventually have ten buildings on that land each approximately 20,000 square feet.

We currently have one tenant occupying the first building. We secured the Conditional Use Permit and Regulatory Permit for this tenant. Now we are expanding the Conditional Use Permit with the city and are pre-qualifying other tenants now. We will then secure the regulatory permits for the new clients which will allow them to occupy and grow in the other 9 buildings. All together, we desire 125,000 share feet of rentable warehouse space occupying 7.5 acres. It is going to be safe secure and green. We are also working with a Southern California based real estate firm to assist with the property acquisition in DHS. This is a company that has developed or re-developed in excess of $2.5 billion in commercial projects!

On your website, it states that Pineapple Express plans to launch a chain of branded retail stores nationwide as soon as it is federally legal to do so. How long do you think it might take for that to happen? Are you currently establishing these retail stores in the individual states that have legalized cannabis?

Pineapple Express intends to be one of the first nationally branded cannabis retail stores, called “Pineapple Express”. We called upon the design folks who created the concept for Jimmy Buffet’s Margaritavilles to create our concept store. I am going to utilize my expertise of opening company owned and franchised stores across the country in creating this chain. I am working with my VP of Business Development Theresa Flynt, who is already planting the seeds for this chain of stores. Right now we are consulting and acting as a landlord. These stores are “Powered by Pineapple Express”. We believe that in approximately three years, the federal government will change the schedule of marijuana from schedule 1 to schedule 2. We also believe that the federal governement will follow the same path that they did with gay marriage. They were watching and learning while certain states made gay marriage legal. Then, more and more states made it legal. Then…before you knew it…the federal government decided to make it federally legal. We see the same kind of momentum happening with legal marijuana right now.

Does Pineapple Express also plan to offer franchisees perks such as collective buying power, marketing materials, and strategic partnerships with producers/processors? Will anyone who meets their state’s requirements for opening a cannabis retail location be able to become a Pineapple Express franchisee?

We will offer franchisees (or licensees) collective buying power, marketing materials, strategic partnerships with producers/processors, and also branding and many other types of industry business expertise.

What do you think is the biggest challenge faced by the cannabis industry in its current state? How can the industry work together to overcome it?

I think the biggest challenge faced by the cannabis industry right now is the lack of professional companies that have proper knowledge needed to really have nationally recognized leaders in the industry. Right now, branding and being a first mover is so important. Once federally legal, big pharma is going to move into this space, along with other really well known companies. That’s why it is so important to be a first mover right now…and to execute properly. We are working diligently in making our brand Pineapple Express known, and soon we will with THC.com. We are also executing carefully and properly. With this, we will grow as the industry grows.

Do you think there is any risk, at this point, of federal action that would undo the progress that has been made by states in dismantling prohibition over the past several years?

I believe there is too much momentum with the legal cannabis industry now to experience any setbacks. There are too many benefits of cannabis. The federal government needs to take cannabis off as a schedule I drug and make it a schedule II drug. This will allow for more federal research and assistance.

What advice would you offer to an aspiring “ganjapreneur?”

Get into the cannabis industry now! You will be upset you didn’t later. There are not a lot of new industries that we will see in our lifetimes. Especially with this much growth and potential. Its like the beginning of the tech industry in the late 1990’s. Or better yet, it is like right after the end of prohibition. We have an employment section on our website and even a place to submit a business plan to. If we don’t have a place for you in our company now, we may later!


Thank you, Matthew, for taking the time to answer our questions and share what Pineapple Express is doing! To learn more about Pineapple Express or to get in touch with them directly, visit PineappleExpress.com. Questions/comments? Post them below!

End


Sean Parker Donates Another $500,000 to California Legalization Measure

Sean Parker, billionaire philanthropist and former President of Facebook, has doubled his donation to the California Adult Use of Marijuana Act (AUMA).

Campaign finance records show that Parker, who first put $500,000 toward AUMA earlier this year, has donated another half a million dollars in support of the bill.

If approved by voters, AUMA would legalize small amounts of cannabis in California for personal possession and use by adults 21 and older. Currently, the proposal’s supporters are collecting signatures to get it on the November ballot, and Parker just gave them a big boost.

Backers have given some $2.25 million in support of the proposal. Besides Parker’s million, money has been flowing in from WeedMaps and the Drug Policy Alliance, each of which gave $500,000, as well as $250,000 from Progressive Auto Insurance chairman Peter Lewis’s political action committee.

Parker has yet to say what his reasons are for putting $1 million behind the campaign, but AUMA’s backers aren’t complaining. AUMA now has more money on hand than did Proposition 19, the previous attempt to legalize cannabis in California. George Soros donated $1 million to Prop. 19 the week before it was voted on, but besides Soros, the only real funder behind the campaign was Oaksterdam University founder Richard Lee, who spent $1.9 million on it. In contrast, Oregon’s Measure 91 had almost $7 million behind it, or $5 per vote.

Although Parker’s reticence has only fueled the mistrust of some in the cannabis industry regarding AUMA, Anthony Johnson, the  chief petitioner of Oregon’s Measure 91, says Californians should still get behind it.

“If it’s better than prohibition, you should support it,” he said.

End


Washington Passes Bill for Industrial Hemp Research Plots

The Washington state Senate passed SB 6206 last week, which authorizes certain individuals to grow pilot crops of industrial hemp for research purposes. The bill passed on a vote of 48-1.

Though Washington was among the first states to legalize recreational cannabis, it has remained behind the times in regards to industrial hemp cultivation, until now.

SB 6206 is inspired largely by the 2014 Farm Bill, which opened up the opportunity for states with hemp cultivation laws to begin planting pilot crops without fear of federal repercussions. Hemp farmers would have to register with and be licensed by the Washington State Department of Agriculture (WSDA). Individuals with a felony drug offense from within the last 10 years would be barred from the program, though hemp itself is non-psychoactive.

“This is the responsible route to take,” said Washington hemp lobbyist Joy Beckerman. “Our department of agriculture has gotten impressively sophisticated year by year.”

WSDA policy assistant Steve Fuller told Capital Press that he’s been consistently receiving at least one phone inquiry per week about the legal status of industrial hemp. “There has been a good amount of interest in the possibilities,” he said. “Anytime there’s a new agricultural opportunity out there, we like to try to support it.”

The WSDA said it will need $145,000 for the program, which could be ready to roll out by the 2017 growing season.

End


Oregon's state capitol building, pictured on a sunny winter day.

Oregon Legislature Considers Major Cannabis Changes

On Monday, Oregon state lawmakers voted on some potentially serious changes to current marijuana laws.

The 35-day session of the Oregon legislature began February 1st, and has been packed with legislation to raise the minimum wage, overhaul medical and recreational marijuana, and attempt to solve the housing crisis. But Republicans have employed a rarely-used procedural move that forces fellow lawmakers to read every single bill in its entirety, out loud — delaying votes on important legislation.

One of the first marijuana bills on the docket on Monday, HB 4014, removes the two-year residency requirement on out-of-state investors wanting to get a piece of Oregon’s legalization pie. The bill’s other provisions give veterans a significant discount on registration fees for obtaining a medical marijuana card, and provides other medical benefits.

The 51-page bill was read out loud the legislature, taking hours, and stranding many lawmakers who were supposed to be meeting on other committees to debate renter relief legislation.

After the read-aloud session was finally over, the bill passed 48-11.

Additional measures that were supposed to be addressed on Monday: HB 4094, which would relieve banks from criminal liability for doing business with the cannabis industry, and is expected to open up banking for the currently cash-only marijuana business in the state; and SB 1511, which would allow tax-free sales of medical marijuana to card-holding patients.

End


New Mexico Senate Blocks Move to Let Voters Decide Recreational Cannabis Issue

Legislators in New Mexico defeated a proposed bill that would have put the issue of cannabis legalization into the hands of voters.

The New Mexico Senate voted down Senate Joint Resolution 5 by a vote of 24-17. The resolution, sponsored by Senator Gerald Ortiz y Pino (D-Albuquerque), would have put the question of legalizing recreational cannabis to voters this November.

Voters would have been given the option of legalizing marijuana for recreational possession and use by adults 25 or older. The proposal had initially put the age requirement at 21, but it was amended to change the minimum age to 25.

In the event that voters approved the proposal, the state legislature would have had to pass legislation to create a recreational cannabis regulatory system.

Prior to the vote Sunday, Republican lawmakers argued against the bill. Senator Sander Rue (R-Albuquerque) voiced concerns that children would be at risk of getting a “contact high” from being near adults who were smoking cannabis. Sen. William Sharer (R-Farmington) claimed that today’s cannabis is “so potent, it becomes addictive.”

Six Senate Democrats were among those who voted against the resolution, though it’s unlikely that the bill would have passed the Republican-controlled House.

More than 60% of New Mexicans support legalizing retail cannabis, according to poll numbers from January.

End


Washington Experiences First Cannabis Recall Due to Pesticides

For many months, marijuana product recalls stemming from the use of prohibited pesticides have been a consistent problem in Colorado, while Washington seemed, for a while, to be free of such concerns. On Friday, however, Washington-based cannabis wholesaler Evergreen Herbal issued the state’s first voluntary pot product recall due to pesticide concerns.

The recall is thanks to unfortunate growing mishaps by two producers — New Leaf Enterprises and BMF Washington — who were recently investigated by the Washington Liquor and Cannabis Board (LCB) for the use of prohibited pesticides.

New Leaf Enterprises, makers of the popular Dama line of cannabis products, has been fined $2,500 for a first violation and was given a temporary stop sale order from the LCB. New Leaf co-owner Boris Gorodnitsky managed to get the stop sale lifted after privately testing his products and the products of several competitors for pesticides. It was shown that the traces of prohibited pesticides uncovered by the LCB were in fact only residual traces inherited from New Leaf’s mother plants, which had been originally sourced from the unregulated medical market, where pesticide control was not as prevalent.

BMF Washington was also issued a $2,500 fine, but an investigation has revealed that the pesticide issues at BMF were much more rampant — of BMF’s 17 pesticides that the LCB investigated, 12 were in fact prohibited and were being used directly as part of the cultivation process.

Evergreen Herbal announced its voluntary product recall via press release on Friday evening. The three products facing recalls are all high-CBD edibles: the Hibiscus Quencher, Strawberry Quencher, and CBD Dark Chocolate 420 Bar. According to the press release, these three products were at one point produced using Dama CBD oil.

Only the Evergreen Herbal products that were manufactured before November 12, 2015 may be affected, but CEO Marco Hoffman believes that — even though most of the affected products have likely already been distributed — it was the responsible decision to stick with a voluntary recall.

In an exclusive interview with Ganjapreneur, Hoffman pointed out that even though these are particularly regrettable circumstances, “I think it’s really important that we realize that no-one has gotten sick…. And how ultra responsible the people in the cannabis industry are.”

“If only every other industry acted as we did, we would live in a completely different world right now,” Hoffman said. “I think they both made honest mistakes and they should be given the ability to learn from it.”

The press release issued by Evergreen Herbal is attached below:

Today, we learned of the article in The Seattle Times regarding prohibited pesticides used in recreational marijuana produced by New Leaf (Dama). We have determined that the only Evergreen Herbal products that may be affected are products that contain CBD oil purchased from Dama. The affected batches were manufactured before November 12th, 2015.

Please note that NO Dama flower, trim or oil has been used in the production for our LoudVape concentrates (Live Resin, Wax & Shatter, and Cartridges). This distinction is important because the CBD Dama Oil was limited to Evergreen Herbal CBD edibles (Hibiscus Quencher, Strawberry Quencher, and CBD Dark Chocolate 420 Bar). According to a Dama representive their CBD oil did not test positive for the chemical. The chemical deemed dangerous, myclobutanil, is most harmful when heated and inhaled. More information can be found here:

http://www.seattletimes.com/seattle-news/marijuana/pot-products-recalled-in-colorado-for-pesticides-but-not-in-washington/

Evergreen Herbal, in its commitment to safety and integrity, is issuing a voluntary recall of products containing Dama oil. This is a voluntary recall and no formal recall has been mandated by the WSLCB. The lot numbers for edible products containing Dama oil are listed below. Our commitment to high quality and safe products will continue to be our priority, and we will gladly address all questions and concerns.

Your understanding and patience while we work to resolve this issue is appreciated. Thank you for your continued business and support.

Last Four Digits
Strawberry – 2605, 2476, 1357, 1913, 0605
Hibiscus – 2119, 1788
CBD Dark Chocolate – 5430, 5742, 5429

Sincerely,

The Evergreen Herbal team

End


New Hampshire House Kills Cannabis Legalization Proposal

The New Hampshire House has voted against a bill that would have legalized the possession and cultivation of cannabis, as well as established a regulatory system for its commercial sale. The law, House Bill 1694, was one of three legalization proposals facing the House this session.

The bill would have included a hefty excise tax of $530 per ounce of cannabis flower and $15 per ounce of anything else derived from cannabis.

HB 1694 was sponsored by Reps. Geoffrey Hirsch (D-Merrimack), Joseph Lachance (R-Hillsborough), John O’Connor (R-Rockingham) and Mario Ratzki (D-Merrimack).

Rep. Hirsch commented that HB 1694 would have provided New Hampshire citizens with “…a controlled, tested, labeled, and less harmful alternative to alcohol” — a perfectly legal substance which in the U.S. alone claimed 50,000 lives last year, reports Gary Rayno of the State House Bureau.

The New Hampshire House has passed decriminalization bills in the past, but each time the Senate has eventually shot them down.

Cannabis reform is guaranteed to be a hot topic this election season, with several other New England states currently considering legalization laws and a growing number of voter initiatives coming online elsewhere that are aimed at the repeal of cannabis prohibition.

End


Marijuana Policy Project Launching New MMJ Initiative in Ohio

The Marijuana Policy Project (MPP) plans to launch a medical marijuana initiative in Ohio with new organization “Ohioans for Medical Marijuana,” after last year’s “Issue 3” by ResponsibleOhio failed at the polls.

The new initiative would allow the opening of state-licensed dispensaries, give patients suffering from serious conditions such as cancer and Crohn’s disease access to medical cannabis, and allow home cultivation. It’s a more restrictive program than the one pitched to voters last year by the now-defunct ResponsibleOhio, which critics claimed would have established a cannabis monopoly in the state.

Mason Tvert, the MPP’s Director of Communication, said that the failure of Issue 3 doesn’t reflect the national tone on medical marijuana.

“It only reflects where Ohio voters stand on a specific and rather unique proposal in an off-election year.” As many as nine out of ten Ohio voters supports legalizing medical marijuana, and 56 percent of the state’s voters support legalizing recreational marijuana.

Ohioans for Medical Marijuana has just begun its work, said Tvert. “We are in the very initial stages of this process—filing a committee, starting to build a campaign team, and conducting outreach to potential coalition partners and donors.”

Another group called Legalize Ohio also plans to put an initiative for full recreational legalization in front of voters in November, ensuring 2016 will be an interesting year for cannabis legalization in Ohio.

End


Pennsylvania Medical Cannabis Law is Stalled, But Not Dead

“We need to get this done,” Pennsylvania Governor Tom Wolf told a crowd of supporters at the Pennsylvania State Capitol medical marijuana rally held on February 8th, 2016.

The rally was to show support for Senate Bill 3, the bill to allow Pennsylvanians suffering from certain conditions to use medical marijuana to alleviate their pain. The bill was passed in the state Senate, but stalled when it reached the House of Representatives. In the House, more than 200 amendments to the bill were proposed by representatives and it still has not been called to a vote. At the support rally, Governor Wolf placed the blame for the delay on Speaker of the House Mike Turzai, answering “why don’t you go ask him?” and gesturing toward Turzai’s office when a member of the crowd asked why the bill had not been passed yet.

Multiple polls have shown that the majority of Pennsylvania residents are in favor of a state law allowing the use of medical marijuana. The most conservative measure of public opinion, found through a poll conducted by Robert Morris University, found that 67.5% of Pennsylvania residents polled were in support of such a measure. Other polls, including ones conducted by Quinnipiac University and the Mercyhurst Center for Applied Politics, found that 69% to 88% of Pennsylvania voters were supporters of medical cannabis. This is in line with national polls, which have found that approximately 80% of American adults are in favor of legalizing marijuana for medical use.

So why hasn’t the bill been passed already?

Because opponents in the House are doing all that they can to keep it from passing. Initially, Turzai assigned the bill to the House Health Committee, which is chaired by Representative Matt Baker, who stated that we do not have sufficient evidence of marijuana’s medical benefits, citing the white paper “Is Marijuana Medicine?,” released by the Pennsylvania Medical Society. He further argued that it would be unwise to approve its use while the FDA has not officially done so.

A House member then filed a discharge petition that brought the bill to the House Rules Committee, where a new version was drafted by a bipartisan group of representatives. Then came the amendments and budget issues.

“The budget blew everything up. There was no oxygen to discuss anything mildly controversial. That’ll change,” Representative Peter Schweyer told Bill White of The Morning Call in an interview. “There is a segment of the Republican caucus who will do everything to kill it, including Chairman Baker. But I also know a majority of House members support this, including a number of Republicans.”

Progressive marijuana reform can’t come soon enough for many Pennsylvanians, which was noted by Schweyer in the interview and Wolf at the rally. Facing the mock-up doctor’s office full of supporters dubbed the “Still Waiting” room at the state Capitol, Wolf did not mince words about his feelings on the issue.

“Get it to my desk, and I’m going to sign it,” he said.

End


Vermont Police Dogs No Longer Being Trained to Detect Cannabis

In a move that showcases the national spread of cannabis normalization, police dogs in Vermont — in anticipation of the state’s likely legalization of marijuana — are no longer being trained to recognize the plant’s smell.

Robert Ryan, head K-9 training coordinator for Vermont, told The Times Argus that the change was actually first proposed last year, though not put into effect until this year’s course.

Currently, Vermont is poised to become one of the first states in the nation to legalize cannabis through legislative action, not a voter initiative. Legislation to such an end is expected to soon appear in the state Senate for discussion.

Cannabis, because of its potent odor, is easier than most other substances for dogs to learn to detect, Ryan explained. “If for some reason it doesn’t become legalized, it’s an odor that [dogs] can be trained to alert on later,” he said.

“The dogs that are already trained to smell marijuana are still going to be used,” Ryan said, though they would be reserved only for situations where cannabis would still be worth detecting — like prisons and public schools, for example.

 

End


California Lawmaker Introduces New Bill for 15 Percent Tax on MMJ

Under a new bill introduced Wednesday by state Senator Mike McGuire (D-Healdsburg), called the Marijuana Value Tax Act, California would see a tax hike up to 15 percent on medical marijuana to fund land restoration and rehabilitation programs.

The tax could go even higher if SB987 becomes law, as the 15 percent figure does not include local taxes that cities and counties may choose to levy. Eddie Miller, chief strategy officer for GreenRush.com, said, “I won’t say it’s not excessive — it is excessive, but it really provides a budget for the state to make it a legitimate industry like alcohol, tobacco or even gambling.”

The new bill could bring in $100 million in tax revenue to California, a state that claims “steep costs” associated with marijuana-related activities — mainly cultivation. Last year, Former Republican state Sen. George Runner described the effect of these activites as “trespass[ing] on public lands, water theft and unregulated use of pesticides.”

The new tax comes after a regulatory framework was finally put in place last year on licensing marijuana-related businesses. California’s legal medical marijuana industry went unregulated for nearly two decades.

Several ballot initiatives are being proposed to legalize recreational marijuana in November. One in particular would use the same tax structure as the new proposed medical cannabis tax.

To pass into law, the bill will still need to win approval from two-thirds of state lawmakers.

End


Anchorage Assembly Finalizes Recreational Cannabis Regulations

The Anchorage Assembly finalized regulations for the recreational cannabis industry this week, The Alaska Journal of Commerce reports.

Many restrictions have been tightened — particularly relating to property buffers between marijuana businesses and sensitive locations such as schools, parks, and other cannabis retailers. The buffer has been reworked from 1000 ft. to 500 ft., which may seem to be more favorable toward cannabis businesses, but now the distance is considered as the crow flies and from property edge to property edge (before, it was measured as a pedestrian’s route between building entrances).

Ultimately, the changes have negatively effected several business owners who had been preparing to apply for a license later this month. “Many of my clients’ spaces were fine this morning,” said Jana Weltzin, an attorney specializing in cannabis business. “And as of tonight, many are now back to square one after months of careful property location scouting and efforts.”

The outlying communities of Chugiak and Eagle River also faced severe zoning restrictions against legal cannabis, angering some residents who argue that, as Anchorage taxpayers, they deserve a fair chance at joining the regulated industry.

The Anchorage Assembly also considered and ultimately tabled a ban on marijuana clubs in the city, though it did pass regulations preventing on-site consumption in retail stores themselves. Meanwhile, it remains unclear whether or not regulations at the state level will allow for the continued existence of cannabis social clubs.

Starting February 24, the Alaska Marijuana Control Board will have application forms available on its website for hopeful recreational cannabis businesses.

End


World’s First Cannabis Business Cruise Scheduled for October, 2016

Update, 9/12/16: We checked in recently to ask, but have not heard whether the cruise mentioned in this story will be moving forward. If you are looking for a cruise vacation to a cannabis-friendly location, we consider checking on Expedia and Priceline for cruises that include stops in Jamaica.


The U.S. cannabis industry has witnessed some amazing developments, but now marijuana entrepreneur James Lee is preparing to offer a deal that some years ago would have been considered little more than a pipe dream.

On October 24, 2016, a commercial-grade cruise liner filled with cannabis professionals will depart from Florida for Jamaica, where they will be greeted with an epic all-you-can-consume cannabis trade show specifically tailored for the business-minded cannabis consumer.

This is definitely going to be something the industry has never seen before,” Lee told Ganjapreneur. He is the founder and CEO of Skill Stix and Dabvertising, but his true calling in cannabis may soon be tied to the hospitality industry.

To answer what is likely the first question on everyone’s mind: no — due to international laws, the cruise ship itself will not be cannabis-friendly.

“It’s take what we can get,” Lee said. “There is no way to legally have anything onboard the ship. It’s just impossible, the Coast Guard would seize the ship.”

The project has been in the works for about a year, he said. After facing countless rejections, Lee eventually enlisted the help of his friend’s company Canna-Travel to share in some of the outreach efforts. Together, the team landed a deal with what Lee claims is one of the best-positioned international cruise companies in the world. The deal was finalized February 3.

“We went as a duo to this major industry and said, ‘look, this is what’s on the line,'” Lee said. “‘We’ve got this money…. We have everything, down to designs for the placards they’ll wear around their necks. We have everything, we just need a ship.'”

More information  — including which major cruise line is involved, as well as likely ticket prices and sponsors for the event — will be announced sometime in March.

End


Australia Set to Legalize Medical Cannabis for Clinical Trials

Australian legislators have introduced a bill to Parliament that would legalize the cultivation of cannabis for medical and scientific use in clinical trials, Reuters reports.

The legislation would provide for the creation of a national regulatory system for the licensing of medical cannabis growers and processors. Patients suffering from painful and chronic conditions would be able to get access to marijuana as part of clinical trials.

Current law prohibits cannabis cultivation, though certain Australian states have decided to begin clinical cultivation trials for medical and scientific purposes. Participants in the clinical trials have so far been forced to depend on costly imported products.

Australian Health Minister Sussan Ley said that “allowing controlled cultivation locally will provide the critical missing piece for a sustainable legal supply of safe medicinal cannabis products for Australian patients in the future.”

The new legislation would not make medical cannabis available to those who are not part of clinical trials, though the country will decide by the end of March as to whether it will modify the criteria for access.

Currently, the country allows patients suffering from chronic pain to access opium, and cannabis could be included in the same category.

Gaelan Bloomfield, manager at MMJ PhytoTech Ltd, Australia’s first publicly-listed medical cannabis company, said that “the market for medicinal cannabis in Australia is substantial. The number of patients that could be targeted could be people with epilepsy, Multiple sclerosis, while there is the other spectrum of people with chronic pain.”

End


WA Department of Health Does Not Support Specialty Clinics for Medical Cannabis

Officials from the Washington State Department of Health issued an email this morning over the state’s medical cannabis Listserv that will surely spell disappointment for medical cannabis patients around the state.

When the Washington legislature passed the Cannabis Protection Act during the 2015 legislative session, the Department of Health was tasked with developing recommendations regarding potential specialty clinics that would be authorized to dispense medical cannabis to patients so long as the health care professionals involved are certified as medical marijuana doctors by the state.

The official recommendation was announced this morning: “The department does not support establishing medical marijuana specialty clinics in Washington at this time.”

Officials listed the following reasons as their rationale:

  • Healthcare practitioners cannot legally prescribe or dispense Schedule I controlled substances and would potentially risk criminal prosecution, as well as civil and financial liability.
  • Injured patients may be left without an adequate remedy if malpractice does occur.
  • Further research using accepted scientific protocols is needed.
  • Significant changes to existing licensing laws for commercial marijuana would be needed. Without such changes, practitioners at specialty clinics would not be able to access the marijuana they would later dispense to patients, which could present issues with supply.

Instead, the department recommends that individual practitioners take it upon themselves to familiarize themselves with the potential risks and benefits of medical cannabis. The full report is available on the department’s website.

End


Martin Lee: Educating the Public About Medical Cannabis

Martin Lee is co-founder and director of the California-based Project CBD, a nonprofit dedicated to the promotion and publication of cannabis-focused research — particularly investigations into the medicinal applications of cannabidiol (CBD) and other components of the cannabis plant. Martin has worked as an award-winning investigative journalist, covering the development of medical cannabis for years in the pages of O’Shaughnessy’s. He also authored Smoke Signals: A Social History of Marijuana, and before that, Acid Dreams: The Complete Social History of LSD. He received the Pope Foundation Journalism Award award for his investigative journalism in 1994.

Martin recently joined Ganjapreneur podcast host Shango Los for a discussion about how the conversation around cannabis — particularly CBD and the plant’s apparent myriad medicinal uses — has been slowly evolving in mainstream media and the overall American society.

Subscribe to the Ganjapreneur podcast on iTunes, Stitcher, SoundCloud or Google Play.


Listen to the podcast


Read the transcript

Shango Los: Hi there and welcome to the Ganjapreneur.com podcast, I am your host Shango Los. The Ganjapreneur.com podcast gives us an opportunity to speak directly to entrepreneurs, cannabis growers, product developers and cannabis medicine researchers, all focused on making the most of cannabis normalization. As your host, I do my best to bring you original cannabis industry ideas that will ignite your own entrepreneurial spark and give you actual information to improve your business strategy and improve your health and the health of cannabis patients everywhere.

Today, my guest is Martin Lee. Martin Lee is co-founder and director of Project CBD, a California based non profit dedicated to promoting and publicizing research into the medical uses of cannabidiol and the other components of the cannabis plant. He is author of Smoke Signals: A Social History of Marijuana. Martin also co-authored his first book, Acid Dreams, the CIA, LSD and the 60’s Rebellion in 1985. As a journalist, Martin covered the medical cannabis movement for years in the pages of O’Shaughnessy’s and he was awarded the pope foundation award for investigative journalism in 1994.

Thanks for being on the show Martin.

Martin Lee: My pleasure.

Shango Los: So Martin, well many of our audience folk are familiar with the basics CBD and the endo-cannabinoid system, it’s barely been discussed prior to the last four or five years when it began to gain a wider media attention. What about the American zeitgeist has prevented CBD to be popular until just now?

Martin Lee: Well it’s interesting. When we first launched Project CBD six years ago, we had a sense that it could be a real game changer for the medical marijuana situation, that it could help to liberate cannabis from the confines of the drug abuse paradigm. I think events have born us out on that but it really took the CNN broadcast in the summer of 2013 which showed the dramatic outcomes for children with pediatric epilepsy when they were administered CBD rich oil. That was a tipping point.

I think the zeitgeist was ready for that and we’ve been in the midst of long standing pro-cannabis cultural shift but I think CBD has accentuated that shift quite dramatically and really changed parameters of the game so to speak. I think the zeitgeist was being prepared for awhile and people are ready for this I think because there was great dissatification prevalent for the typical medical options, corporate medical options, big pharma and so forth. So it’s not surprising to us that CBD sort of triggered a popular upsurge of interest and I think that will continue. We see a big surge of newcomers so to speak into the medical marijuana milieu who are looking for cannabis products, cannabis remedies that don’t necessarily get them high because many people don’t enjoy the cannabis high and those that don’t can now benefit therapeutically from certain cannabis strains, certain cannabis products because CBD is not psychoactive the way THC is. It can neutralize or at least lessen the psycho-activity of THC so it means that all those people who for one reason or other were not inclined to reach for cannabis as an option therapeutically now can do so.

I think that bodes well for the future in terms of the medical marijuana situation.

Shango Los: You know that’s a really good point Martin. When you start allowing people to find out a new way to heal themselves, that in and of itself will change people’s expectations. Up to just a few years ago, people were only thinking about cannabis as an intoxicant only and the fact that CBD is not psychoactive and actually you know we’ve seen all the images now of it healing children, which really gets to people’s hearts.

Were you involved at all with Sanjay Gupta coming to this realization with CBD or were you watching it like the rest of us and seeing an opportunity now to do more outreach for education?

Martin Lee: Well at Project CBD we knew several months ahead of time that that program was coming because we were in touch with the doctor who was guiding little Charlotte and her family in terms of the cannabis therapeutic approach that they were pursuing so we knew that was coming, we expected it but there’s no way one could really be prepared for the onslaught that happened afterwards.

That really dramatically changed the conversation, the national conversation about cannabis. I mean prior to that show, that public conversations, the public discourse was still bogged down in questions like well does medical marijuana really work? Is it just a front for stoners? It’s just an excuse for people to get high, that sort of thing. What kind of damage will it do to my child’s brain if they’re exposed? Those were the key questions that were being discussed, let’s say before CBD if we could put it that way.

Now the key question is not does it work but how we can best use cannabis therapeutically for maximum benefit. Not what harm will it do my child but how can I access CBD rich oil to save my child’s life so there’s been a dramatic change there and I say that this shift has been long in coming. It did take that national television broadcast to function as a tipping point but you know a lot had been happening before that to lay the ground work to make that tipping point possible.

Shango Los: It’s a shame that you know it had to be sick children that was necessary to bring that to the forefront but at the same time we’re all grateful that it has played out as it has because now CBD is increased in awareness and everyone has got an opportunity to participate and seek out the medicine. You know we had Dr. Ethan Russo on the program discussing endo-cannabinoid deficiency last year and his ideas were very clear yet because he is a scientist, he speaks in a language that is a bit unfamiliar to most lay people. For yourself as both a journalist and a CBD evangelist, what do you see as some of the challenges of translating the benefits of the detailed CBD molecule to the general public so that they can learn en masse?

Martin Lee: Well the endo-cannabinoid system is quite fascinating as an intellectual area, a scientific area but it’s true. It’s difficult for non-scientists to understand sometimes what scientists are talking about. Scientists tend to talk to each other. It’s kind of like a hermetically sealed environment and I think that’s one of the roles that Project CBD had always envisioned for itself is to translate the science so that it’s accessible to the medical marijuana community, the public at large and I’m not including doctors and physicians in that who are not necessarily steeped in this science but how can we sum up the endo-cannabinoid system. If you want to talk about the particulars, we would think of three components.

There are receptors in the brain that respond pharmacologically to compounds in cannabis. The receptors in the brain and throughout the body. There are also androgynous compounds that are marijuana like molecules that our own brain, our body creates. They’re similar in effect to the compounds in the plant but exist naturally in all mammals. Actually in all animals but for insects. Then there are also enzymes in the body that help to create these androgynous compounds and help to break them down. It modulates the levels of our own cannaboids and Dr. Ethan Ruso has made a very important contribution with this notion of endo-cannabinoid deficiency. That if we are lacking or we have low levels for one reason or another. Maybe it’s genetics, maybe it’s the wear and tear of stress throughout one’s life that our levels of our own marijuana like molecules become depleted and then we become very vulnerable to all sorts of diseases because the endo-cannaboid system has a neuroprotective function. It literally protects cells against degeneration.

I know we’re kind of getting into science speak but I just think of the endo-cannaboid system as the fulcrum of health and as we live out our years and accumulate stress because stress wears down the endo-cannabinoid system. People as they get older tend to get sick. While it’s not simply a matter of depleted endo-cannabinoids, there are other factors obviously at play. This is very very important physiological system because it regulates pretty much all the other systems. You know when we were taking high school biology we were taught about that we had a skeletal system, an immune system, a reproductive system, hormonal, et cetera et cetera but we never were taught that we had an endo-cannaboid system because we didn’t know about this scientifically until really the 1990’s and still it’s not even taught in medicals schools which is quite shocking because it’s so fundamental to health.

Shango Los: Sure is. Yeah.

Martin Lee: I think of it as like the dowel of health, the endo-cannabinoids. It’s the balance point. If you have a healthy balanced endo-cannabinoid system you will be a healthy human being.

Shango Los: It always reminds me a lot of the term tutonify in oriental medicine where it’s not that you’re pumping something up or you’re not that your depleting it is that you’re looking for a balance in the middle where all of the systems can run effectively and the endo-cannabinoid system seems to be that tantivying system that helps all the other systems click along.

Martin Lee: Yes there’s actually the phrase endo-cannaboid tone but what’s interesting when we speak about the cannabis plant and what’s all important here is the whole plant and how it interacts with our own physiology and how it interacts with the endo-cannabinoid system. The cannabis plant is a very unusual plant. It’s what called an herbal adaptogen and one of the features of that it has a way of balancing one’s system so that it basically can calm the hyper, it can energize the sluggish. It has a way of balancing both excess and deficiency so the same strain, literally the same remedy can have different effects for different people depending on what their condition is and what their imbalance is and that’s one of the beauties and the magic of whole plant cannabis.

Shango Los: Thank you for that explanation Martin. It’s very insightful to realize that the same plant can effect two people differently. It certainly makes it more challenging to recommend strains to friends but it sure makes a lot more sense with how our bodies interact with it. It’s time for us to take a short break. We’ll be right back. You are listening to the Ganjapreneur.com pod cast.

Welcome back. You are listening to the Ganjapreneur.com pod cost. I am your host, Shango Los and our guest this week is Martin Lee, author of the book Smoke Signals and founder of Project CBD. So Martin, before the break we were talking about endo-cannabinoid deficiency and the powers of cannabidiol and cannabidiol is just one of the cannabinoids in cannabis. Most of the plant remains unresearched but as a researcher I’m sure that you’re starting to get ideas of what else we might uncover in the plant.

Can you tell us a little bit about the yet unresearched aspects of the plant that we’re looking forward to?

Martin Lee: There’s a whole world there, it’s a very good questions and it’s a fascinating area. If we just focus on the cannabinoids in particular, there is about a hundred different cannabinoids of which CBD and THC are the most well known and well studies. There are others. One that’s coming up now on the radar is THCV, it’s kind of a variation on THC. THCV has the opposite effect in some ways for THC in that it, well THC stimulates the munchies, THCV has the opposite effect, it kind of mitigates appetite. It’s beginning to be looked at as something possibly for metabolic syndrome and obesity. We have to keep in mind that cannabis isn’t just cannabinoids in the plant. There are flavanoids, there are terpenes and all these different components of the plant have specific medical attributes but when you combine them all together they create what scientists call the entourage effect or ensemble effect so that the therapeutic impact of the whole plant is greater than the sum of the parts.

Just looking at the terpenes for example, these are the essential oils that give the plant its smell. CBD and THC have no smell. We all know that cannabis has a very very potent smell and each strain has it’s own unique smell and there’s something about that that’s very important. The smell that resonates for the patient is probably the one that works for best for them, the one that will resonate with their own physiology but there is for example a terpene called betacaraethylene. There’s actually a terpene called betacaraethylene that’s very prominent in many different cannabis strains and betacaraethylen is unique among terpenes in the plant in that it’s the one and only one that we know of that actually binds directly to one of the cannabinoid receptors. There’s two known receptor systems.

CB1 receptor systems are primarily in the brain and central nervous nervous system. It mediates psycho-activity and many other things but the CB2 receptor, very very important. It’s prominent in immune cells and the peripheral nervous system and metabolic tissue and this betacaraethylene terpene binds directly to the CB2 receptor which modulates inflammation and inflammation underlies so many different conditions that it’s very important if you have substance that will actually turn down inflammation and if it hits that CB2 receptor, that’s what it will do. It modulates inflammation and so then I think that something in the future we’re likely to see in cannabis products, is something with a little extra betacaraethylene added to it and betacaraethylene incidentally is available in many different herbs, not just cannabis. It’s very prominent in echinacea for example. Echinacea is betacaraethylene rich so that’s one of the reasons why as an herb echinacean is know for something that’s good for the immune system. It’s actually in many other herbs, black pepper for example.

So that’s just one aspect of what’s possible with scientific research into cannabis. Looking at all the different aspects of the plant and we can modulate by looking at all different aspects of the plant and what’s in it. We can kind of tailor made by looking at all different aspects of the plant and different components in it, we can tailor different products to suit specific therapeutic needs and that’s very exciting.

Shango Los: Do you think that with the help of technology we now have been able to tease apart all the different components of the cannabis plant that we know what is there and no it’s just a matter of going through and researching the different aspects or are we still at a point where there are components of the plants that we have not even identified yet and so we’re still unpacking the plant to know what’s even there?

Martin Lee: Well I think the latter is true, that we still, there’s a lot mystery to the plant. One very exciting area of technology is a gene sequencing of the cannabis plant. The cannabis plant has been gene sequenced so has the human being and I think one area that’s going to be gaining more prominence in the future is matching what we know about the cannabinoids in the plant based on the gene sequencing and figuring out how that relates to human beings. There are conditions such as epilepsy for example where scientists now can sequence the genes of an epileptic patient and find out what genes have what’s called polymorphisms, or mutations in the gene. They’re finding out now for example why it is that CBD rich oil works better for certain children with pediatric epilepsy and why it has no effect on others. Why it doesn’t seem to help others because they can see what’s happening in the child in terms of what genes are mutated.

For Dravet syndrome for example and Doose, another epileptic condition, pediatric, that’s very very damaging for a child, they respond very very well to CBD rich oil. For some other people or some other children, CBD might not be their molecule. It might THC or THCA, THC in it’s acid form which is non-psychoactive by the way. That’s how it actually appears in the plant. For the plant to get you high, you have to heat it. This is a fascinating area where we’re just at the beginning of, we’re in threshold I think of major discoveries that will match the specific components of the plant to what is happening specifically with people and their conditions.

Shango Los: One of the questions that I get all the time is what ratio of CBD to THC works for particular conditions. For example, something that’s a two to one tends to work out really well with folks with Parkinson’s but that would actually make many children lethargic in dealing with their seizures. When you are explaining CBD to THC ratios to people so that they can really grok it, what do you tell them?

Martin Lee: Well I think it’s best not think of the ratios in terms of matching it to a particular condition. What’s important is to match the ratio to a person and at Project CBD we do a lot of workshops, staff training at medical marijuana dispensaries and we always tell the budtenders, as they’re called, the people who are dealing directly with the patients, they’re job given the fact that they really don’t have medical training is not to cure an illness or a disease but simply to help a patient find a comfortable entry point into cannabis therapeutics.

For people who are naive with respect to cannabis, maybe senior citizens, maybe young children, likely a good starting ratio for them would be something that would be CBD dominant with very little THC. It won’t be psychoactive like THC, it won’t get them high or stoned and it’s kind of an easy way for people to start with cannabis therapeutics and for some people that might be the perfect ending places as well. For others who are comfortable with THC because one’s sensitivity to THC is all important here. To what extent one likes to get high, they might start on a ratio that’s one to one, equal parts CBD to THC which may have ultimately a greater therapeutic impact because CBD and THC synergize, they potentate each other, they make each other more a stronger for different therapeutic applications and that’s been show in many different scientific experiments.

Really it’s a matter of what’s the right way for a person to use cannabis in terms of the ratio, not so much what is the perfect ratio for a condition. I’m not sure if we’ll ever find the perfect ratio for a condition because ultimately we’re not treating conditions, we’re treating human beings.

Shango Los: I think that this is a good time for us to plug the great section on your website that talks about conditions. We were speaking in the first segment about how Project CBD seeks to educate folks and make it easier for them to learn about CBD and early on I was continually encouraging people to go to the pubmed.gov website and look up the different THC and cannabis related scientific research that has gone on and sometimes people get to the website and I would just lose them. But then I found the section at projectcbd.org. When you click on conditions, it lists all the different, well not all the different conditions but many of the popular ailments that people are trying to find relief from and when you click on the particular ailment, you’ve done the research work for them at pubmed.gov and it just automatically brings you all of the most recent scientific research on that particular ailment. If you’re listening and you have an ailment and you kind of want to get right to learning, that’s a great place to go so thank you for having that on your site Martin.

Martin Lee: Well we listed fifty different conditions and actually there’s more that could be listed but the requirement for being listed on the website is that has to be some scientific research. I think anecdotal research and reports is very important and very relevant. The cut off for us is there has to be some science there. I should emphasize that most of the scientific research with respect to CBD and cannabinoids and cannabis is focused on individual components of the plant and that is not involving actual whole plant material. It involves individual components of the plant and it’s generally given to animals as pre-clinical research so it’s test tubes, petri dishes, maybe human cell lines but there’s not a lot of clinical data because of prohibition has prohibited clinical research by and large involving cannabis.

That’s important to keep in mind with the provides of that what a single molecule does to the human brain, whether it be CBD, THC or anything else, is different from what the whole plant does. We draw a very important distinction between CBD and CBD-rich cannabis and ultimately Project CBD advocates for whole plant cannabis therapeutics so we coined the phrase I should say my colleague Fred Gardener coined the phrase CBD-rich very early on when the first strains that had a lot of CBD in them were re-discovered in northern California in 2009. Rather than calling it high-CBD we wanted to get away from the connotation of high so we called it CBD-rich.

Shango Los: Right on. That makes a lot of sense. It’s time for us to take another short break. We’ll be right back. You are listening to the ganjapreneur.com pod cast.

Welcome back. You are listening to the ganjapreneur.com pod cast. I am your host Shango Los and our guest this week is Martin Lee, author of the book Smoke Signals and founder of Project CBD. Martin, in the fist segment we were talking about your early days O’Shaughnessy’s, the intense cannabis journal the covers the science behind cannabis and 2010 you and your partner that are at O’Shaughnessy’s, Fred Gardener, decided to launch Project CBD. Your role as a journalist on the cannabis beat for O’Shaughnessy’s and being an educator using O’Shaughnessy’s as the vehicle sounds to me as very similar to your now role as a global educator with Project CBD. What was the opportunity that you and Fred saw that caused you to want to take the step from simply reporting the news in O’Shaughnessy’s to doing outreach to educate folks?

Martin Lee: Well it is true that O’Shaughnessy’s gave birth to Project CBD in 2010 and I’m very thankful for that and Fred Gardener is currently the editor of O’Shaughnessy’s and recently came out with a monumental fantastic issue that anyone who is interested in this area whether as an entrepreneur, a patient or a doctor should get a hold of it. It is a massive issue with phenomenal information, cutting edge science and you can go to beyondTHC.com to find that. In the spirit of O’Shaughnessy’s both Project CBD and O’Shaughnessy’s have tried to speak to the layperson, speak without the heavy scientific jargon to make those concepts that we learn about from the scientists, make them accessible to many people. We decided that once we realize that CBD rich strain were available CBD medicine would become available as a result for medical marijuana patients, we felt that is just warranted it’s own special focus and that’s why we launched Project CBD. Project CBD does have an international audience. We get inquiries from all over the world. I think there was one month we got inquiries from over a hundred and fifty different countries and typically people are seeking information and there is a lot of confusion out there for various reasons.

Often times people contact us and say are they looking for CBD, they want CBD, the medical part of the plant, not the THC, not the recreational part and we have to tell them you know THC is very medical. They work best together and you don’t want just CBD alone, you need THC and CBD together to get the best therapeutic effect. That’s one of the many misconceptions that we try to debunk and so our role as educators has evolved as the whole situation has evolved. Initially it was all about letting people know that there was more to the plant than just THC, that there was more to cannabis therapeutics than just getting high. These days there is a lot more going on now and we focus on really the nuts and bolts of what patients need to do, what they need to know when they’re seeking out CBD rich products, what they need to look for to determine if it’s a good quality product and what they need to talk to their physicians about because physicians tend to be poorly educated.

What they need to do basically to pursue a cannabis therapeutic regimen.

Shango Los: You know we’re down to our last two minutes but I wanted to make sure that we talked about your book, Smoke Signals, which has opened the door to cannabis therapeutics to so many people and those are both patients and pharmaceutical executives both. With normalization expanding, do you think there’s still going to be a place for citizen science and cannabis breeding and healing techniques or do you foresee that cannabis is going to become the domain of pharmaceutical companies who have access to the advanced technology to outpace neighborhood herbalists.

Martin Lee: It’s going to be very interesting how all this unfolds. You remember, cannabis therapeutics has been with us really since before the written word. You know cannabis has a been a friend of humanity since long ago. This is not going to go away. The whole plant cannabis as a therapy will not disappear no matter what but it’s going to be interesting to see how it plays out legally, how the regulatory regime gets imposed. I think it’s very very important that in addition to whatever will happen with Big Pharma and there’s no doubt that CBD as an isolate will become available as an approved just as THC already is in the form of Marinol, a schedule three drug right now. CBD which is not yet legal federally, is not legal in all fifty states in that regard I think one day will become so with a prescription just like THC is.

The problem is it’s the arrogance of Big Pharma. It’s the sense that they feel that their way is the best way when in fact when we look at the studies that have been done coming from Israel recently comparing actually the therapeutic efficacy of single molecule CBD, meaning the Big Pharma way, and whole plant CBD-rich oil, without going into all the details because we don’t have time, the conclusion is very very clear that CBD-rich oil, whole plant CBD is more efficacious and better for patients than CBD as a single molecule and there’s many reasons. I can explain that, that’s a whole other show. Maybe we’ll talk about that some other time.

Shango Los: That’s great and that is a show that we will want all of the legislators in the states where they are passing CBD-only laws, we’ll want them to hear that to realize that whole plant medicine and taking advantage of the entourage effect is the best way to go. Well, that’s all the time we have for today. Thanks for being on the show Martin.

Martin Lee: Thank you very much. It’s been a pleasure.

Shango Los: You can find out more about Martin Lee and Project CBD at their website. ProjectCBD.org. You can find more episodes of the Ganjapreneur podcast in the podcast section at Ganjapreneur.com and in the apple iTunes store. On the Ganjapreneur.come website you can find the latest cannabis news, product reviews, and cannabis jobs updated daily along with transcriptions of this podcast. You can also download the Ganjapreneur.com app in iTunes and Google Play. You can also find this show on the I Heart Radio Network app, bringing the Ganjapreneur podcast to sixty million mobile devices. Do you have a company that wants to reach our national audience of cannabis enthusiasts? Email grow@ganjapreneur.com to find out how. Thanks to Brasco for producing our show, I am your host Shango Los.

End


Mormon Senator Pushes Medical Cannabis Bill Despite Opposition from LDS Church

A bill to legalize medical marijuana in Utah proposed by Senator Mark Madsen — who is also a proud Mormon — now faces new opposition from the LDS Church.

In a state where 288 people died from opioid overdoses in 2014, Madsen has fought to change the perception of cannabis among his colleagues as a safe alternative to potentially dangerous pain medications. He himself suffered an accidental overdose in 2007, when a fentanyl patch burst and Madsen had to be revived by 911.

When Madsen was approached with the issue of legalizing marijuana oil to ease the suffering of children with severe epilepsy, he became a proponent of medical cannabis. But the Church’s public announcement Monday that it would oppose any attempt to legalize marijuana has already set some Utah lawmakers against the bill.

The LDS Church holds a lot of sway over the political tide in Utah, so Madsen has attempted to meet with church leaders to discuss their specific objections. But the Church will only cite “unintended consequences” as their reason for opposing legalization.

But Madsen thinks Utah is owed more. “The people that are affected by it, I think, might be entitled to some kind of explanation,” he said. 

Despite the church’s opposition, Sen. Madsen says he will continue to push legalization because most Utah voters support it. “It would be immoral to back down,” he said.

End


Florida Revises Full-Strength Medical Cannabis Bill for Terminally Ill Patients

A bill that would legalize full-strength medical cannabis for those suffering from terminal illnesses was revived in the Florida legislature Monday.

The bill, which for months was legislatively sidelined, includes a rewrite that sets the number of eligible producers at five.

The House Appropriations Committee approved HB307 by a vote of 9-2, and is headed to the House. If it passes, terminally ill patients will be allowed access to medical cannabis produced by one of the five authorized growers.

In November, as part of the Compassionate Medical Cannabis Act that passed in 2014, the Department of Health granted licenses to five nurseries that have been operating for at least 30 years and can grow at least 400,000 plants. As of now, they will only be allowed to produce low-THC cannabis.

The House bill that would let these nurseries produce full-strength cannabis is sponsored by Reps. Matt Gaetz (R-Fort Walton Beach) and Katie Edwards (D-Plantation).

“If you have a year left to live, you’re going to try whatever you think may be helpful,” said Rep. Shawn Harrison (R-Tampa). “Frankly, you’re not going to care whether it’s legal or not.”

Although allowing terminally-ill patients is clearly a step in the right direction for Florida, many argue that limiting the number of licensed growers to five is economically and morally shortsighted.

Cathy Jordan, 65, who suffers from Lou Gehrig’s disease, said that although she has been willing to grow her own cannabis illegally, “More than five dispensaries should be available because there are a lot of children that need your [the House Criminal Justice Committee’s] help.”

Jody James, speaking on behalf of the Florida Cannabis Action Network, said that “we want to see patients getting this and my biggest concern is that when you only have five dispensaries, they are going to have a market. They are cornering that market.”

End


Obama 2017 Budget Would Lift Restrictions on D.C. Cannabis; Give DOJ More Power

President Obama has released a $4 trillion budget for 2017 that proposes Washington, D.C. be allowed to spend its tax money to implement retail cannabis regulations.

The budget would lift current restrictions on the use of local funds by D.C. lawmakers to create a recreational cannabis regulatory system. The Republican-led Congress passed a spending bill at the end of 2014 — and again in 2015 — that forbade the District from using federal or local money either to legalize cannabis or to reduce criminal penalties associated with its possession or recreational use.

President Obama proposed lifting the restriction in the 2016 budget as well, but the restrictions were re-enacted in December 2015.

D.C. residents voted to legalize marijuana for recreational use in 2014, but lawmakers have been unable to enact any new legislation due to the restrictions.

The 2017 budget would allow the use of local D.C. funds to effect regulatory change on cannabis by defining the funds which the District cannot use as “federal” funds only.

In addition, the 2017 budget proposes removing a section of the current law that stops the Justice Department from interfering with state medical cannabis legislation. In a departure from his generally hands-off stance on state medical marijuana laws, President Obama’s proposed budget would allow the Justice Department to use federal funds to interfere with the implementation of state medical marijuana programs as it sees fit.

End